MacroGenics(DE:M55)
€2.06-0.02 (-3.74%)
DE:M55
MacroGenics financials statements
€2.06
At close:-0.02 (-3.74%)
MacroGenics (M55) Ratios
5 Followers
MacroGenics Ratios
DE:M55's free cash flow for Q2 2026 was $-41.55M. For the 2026 fiscal year, DE:M55's free cash flow was decreased by $-806.00K and operating cash flow was $-40.75M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.10 | 3.92 | 4.48 | 4.57 | 3.75 |
| Quick Ratio | 4.92 | 3.92 | 4.46 | 4.54 | 3.69 |
| Cash Ratio | 1.33 | 3.29 | 1.80 | 2.24 | 1.66 |
| Solvency Ratio | -0.34 | -0.41 | 0.00 | -0.73 | -2.00 |
| Operating Cash Flow Ratio | -1.88 | -1.23 | -1.39 | -1.79 | -1.93 |
| Short-Term Operating Cash Flow Coverage | -15.65 | 0.00 | 0.00 | -18.40 | 0.00 |
| Net Current Asset Value | $ 18.69M | $ 71.89M | $ 105.53M | $ 74.68M | $ 183.93M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.42 | 0.14 | 0.11 | 0.12 | 0.08 |
| Debt-to-Equity Ratio | 1.92 | 0.32 | 0.22 | 0.25 | 0.11 |
| Debt-to-Capital Ratio | 0.66 | 0.24 | 0.18 | 0.20 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.56 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 4.62 | 2.25 | 1.96 | 2.04 | 1.40 |
| Debt Service Coverage Ratio | -4.31 | -52.30 | 1.41 | -22.83 | 0.00 |
| Interest Coverage Ratio | -8.56 | -99.17 | -117.65 | 0.00 | 0.00 |
| Debt to Market Cap | 0.74 | 0.00 | 0.00 | 0.01 | 0.00 |
| Interest Debt Per Share | 1.83 | 0.62 | 0.57 | 0.57 | 0.42 |
| Net Debt to EBITDA | -0.83 | 2.53 | -33.21 | 0.69 | 0.51 |
| Profitability Margins | |||||
| Gross Profit Margin | 71.12% | 91.71% | 85.62% | 95.08% | 96.50% |
| EBIT Margin | -44.67% | -43.76% | -13.34% | -79.83% | -267.20% |
| EBITDA Margin | -39.87% | -38.67% | 3.53% | -71.92% | -252.31% |
| Operating Profit Margin | -48.72% | -74.54% | -294.17% | -80.94% | -268.09% |
| Pretax Profit Margin | -50.36% | -44.51% | -15.84% | -79.83% | -267.20% |
| Net Profit Margin | -49.91% | -45.14% | -15.84% | -79.83% | -267.20% |
| Continuous Operations Profit Margin | -49.91% | -45.14% | -15.84% | -79.83% | -267.20% |
| Net Income Per EBT | 99.11% | 101.43% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 103.36% | 59.71% | 5.38% | 98.63% | 99.66% |
| Return on Assets (ROA) | -29.05% | -25.59% | -3.04% | -41.37% | -60.29% |
| Return on Equity (ROE) | -134.23% | -57.70% | -5.94% | -84.33% | -84.35% |
| Return on Capital Employed (ROCE) | -34.08% | -53.65% | -69.43% | -50.40% | -77.80% |
| Return on Invested Capital (ROIC) | -32.98% | -50.29% | -68.37% | -49.43% | -76.43% |
| Return on Tangible Assets | -29.05% | -25.59% | -3.04% | -41.37% | -60.29% |
| Earnings Yield | -73.39% | -32.90% | -1.52% | -29.06% | -21.01% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.18 | 34.43 | 5.52 | 2.67 | 7.28 |
| Payables Turnover | 9.02 | 2.45 | 1.28 | 1.51 | 0.17 |
| Inventory Turnover | 5.46 | 0.00 | 6.73 | 5.09 | 0.60 |
| Fixed Asset Turnover | 4.21 | 3.48 | 1.25 | 2.64 | 1.39 |
| Asset Turnover | 0.58 | 0.57 | 0.19 | 0.52 | 0.23 |
| Working Capital Turnover Ratio | 0.88 | 0.83 | 0.31 | 0.79 | 0.32 |
| Cash Conversion Cycle | 59.05 | -138.17 | -165.66 | -33.65 | -1479.83 |
| Days of Sales Outstanding | 32.65 | 10.60 | 66.16 | 136.79 | 50.12 |
| Days of Inventory Outstanding | 66.86 | 0.00 | 54.20 | 71.72 | 604.16 |
| Days of Payables Outstanding | 40.46 | 148.77 | 286.02 | 242.16 | 2134.10 |
| Operating Cycle | 99.51 | 10.60 | 120.37 | 208.52 | 654.27 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.28 | -1.09 | -1.26 | -1.42 | -2.40 |
| Free Cash Flow Per Share | -1.31 | -1.15 | -1.29 | -1.47 | -2.50 |
| Dividend Paid and CapEx Coverage Ratio | -42.34 | -18.45 | -44.33 | -24.00 | -23.19 |
| Capital Expenditure Coverage Ratio | -42.34 | -18.45 | -44.33 | -24.00 | -23.19 |
| Operating Cash Flow Coverage Ratio | -0.76 | -1.83 | -2.30 | -2.50 | -5.65 |
| Operating Cash Flow to Sales Ratio | -0.54 | -0.46 | -1.37 | -0.58 | -1.90 |
| Free Cash Flow Yield | -81.58% | -35.42% | -13.42% | -21.98% | -15.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.36 | -3.04 | -65.77 | -3.44 | -4.76 |
| Price-to-Sales (P/S) Ratio | 0.68 | 1.37 | 10.42 | 2.75 | 12.72 |
| Price-to-Book (P/B) Ratio | 1.83 | 1.75 | 3.90 | 2.90 | 4.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.23 | -2.82 | -7.45 | -4.55 | -6.41 |
| Price-to-Operating Cash Flow Ratio | -1.25 | -2.98 | -7.62 | -4.74 | -6.69 |
| Price-to-Earnings Growth (PEG) Ratio | -0.13 | -0.00 | 0.71 | 0.09 | -0.12 |
| Enterprise Value Multiple | -2.54 | -1.01 | 262.16 | -3.13 | -4.53 |
| Enterprise Value | 151.22M | 58.14M | 528.77M | 338.04M | 864.11M |
| EV to EBITDA | -2.54 | -1.01 | 262.16 | -3.13 | -4.53 |
| EV to Sales | 1.01 | 0.39 | 9.25 | 2.25 | 11.42 |
| EV to Free Cash Flow | -1.82 | -0.81 | -6.61 | -3.73 | -5.76 |
| EV to Operating Cash Flow | -1.87 | -0.85 | -6.76 | -3.89 | -6.01 |
| Tangible Book Value Per Share | 0.88 | 1.85 | 2.46 | 2.31 | 4.00 |
| Shareholders’ Equity Per Share | 0.88 | 1.85 | 2.46 | 2.31 | 4.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 2.37 | 2.37 | 0.92 | 2.44 | 1.26 |
| Net Income Per Share | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 |
| Tax Burden | 0.99 | 1.01 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.13 | 1.02 | 1.19 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.94 | 1.19 | 2.91 | 1.38 | 2.84 |
| SG&A to Revenue | 0.26 | 0.48 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.10 | 0.20 | 0.32 | 0.14 | 0.31 |
| Income Quality | 1.09 | 1.02 | 8.63 | 0.73 | 0.71 |
Currency in USD
